Melanie Marin
Obstetrics & Gynecology · New York, NYNPI 1861498834
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $99,500 of the $122,803 with a category attached, or 81.0%. AbbVie accounts for 98.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $91,606 and has fallen 99.5% since, to $472 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $477.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$121K
- Astellas Pharma US Inc$402
- Mayne Pharma Commercial LLC$213
- Pfizer$186
- Lilly USA, LLC$186
- Millicent US Inc$134
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$99,50081%
- Travel & lodging$15,68813%
- Food & beverage$7,5406%
- Education$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 161 | $120,601 |
| Astellas Pharma US Inc | 15 | $402 |
| Mayne Pharma Commercial LLC | 9 | $213 |
| Pfizer | 10 | $186 |
| Lilly USA, LLC | 4 | $186 |
| Millicent US Inc | 8 | $134 |
| Gynesonics, Inc. | 1 | $133 |
| Avion Pharmaceuticals | 7 | $122 |
| Bausch Health US, LLC | 5 | $100 |
| Evofem Biosciences, Inc. | 5 | $98 |
| Myovant Sciences Inc. | 5 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Vertical Pharmaceuticals, LLC | 4 | $82 |
| Exeltis, USA Inc. | 3 | $68 |
| Therapeuticsmd, Inc. | 3 | $61 |
| Coopersurgical, Inc. | 3 | $57 |
| AMAG Pharmaceuticals, Inc. | 3 | $49 |
| Merck | 2 | $33 |
| Duchesnay USA Incorporated | 1 | $25 |
| Aspira Women's Health Inc | 1 | $23 |
| Mission Pharmacal Company | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$103,912
- ORIAHNN$14,177
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$133
- Veozah$125
- ZEPBOUND$125
How this compares
$122,803 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DuaveeEstrogens,conj/Bazedoxifene | 27 | $8,501 |
| Estradiol | 67 | $6,251 |
| YuvafemEstradiol | 12 | $1,546 |
| ProgesteroneProgesterone, Micronized | 20 | $944 |
| ValacyclovirValacyclovir Hcl | 16 | $796 |
| Estradiol (Once Weekly)Estradiol | 14 | $579 |
| Fluconazole | 13 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerDuavee | $186 | $8,50127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Amitasrigowri MurthyNew York$117K
- Suzanne FenskeNew York$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.